FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1975843667> ?p ?o ?g. }

• W1975843667 endingPage "243" @default.
• W1975843667 startingPage "243" @default.
• W1975843667 abstract "Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the West. Oral steroids are the standard treatment. This is an update of the review published in 2005. Objectives To assess treatments for bullous pemphigoid. Search Strategy In August 2010 we updated our searches of the Cochrane Skin Group Specialised Register, the Cochrane Central Register of Controlled Trials (Clinical Trials), MEDLINE, EMBASE, and the Ongoing Trials registers. Selection Criteria Randomized controlled trials of treatments for participants with immunofluorescence-confirmed bullous pemphigoid. Data Collection And Analysis At least two authors evaluated the studies for the inclusion criteria, and extracted data independently. Main Results We included 10 randomized controlled trials (with a total of 1049 participants) of moderate to high risk of bias. All studies involved different comparisons, none had a placebo group. In 1 trial plasma exchange plus prednisone gave significantly better disease control at 1 month (0.3 mg/kg: RR 18.78, 95% CI 1.20 to 293.70) than prednisone alone (1.0 mg/kg:RR1.79, 95% CI 1.11 to 2.90), while another trial showed no difference in disease control at 6months. No differences in disease control were seen for different doses or formulations of prednisolone (one trial each), for azathioprine plus prednisone compared with prednisone alone (one trial), for prednisolone plus azathioprine compared with prednisolone plus plasma exchange (one trial), for prednisolone plus mycophenolate mofetil or plus azathioprine (one trial), for tetracycline plus nicotinamide compared with prednisolone (one trial). Chinese traditional medicine plus prednisone was not effective in one trial. There were no significant differences in healing in a comparison of a standard regimen of topical steroids (clobetasol) with a milder regimen (RR 1.00, 95% 0.97 to 1.03) in one trial. In another trial, clobetasol showed significantly more disease control than oral prednisolone in people with extensive and moderate disease (RR 1.09, 95% CI 1.02 to 1.17), with significantly reduced mortality and adverse events (RR 1.06, 95% CI 1.00 to 1.12). Authors’ Conclusions Very potent topical steroids are effective and safe treatments for BP, but their use in extensive disease may be limited by side-effects and practical factors. Milder regimens (using lower doses of steroids) are safe and effective in moderate BP. Starting doses of prednisolone greater than 0.75 mg/kg/day do not give additional benefit, lower doses may be adequate to control disease and reduce the incidence and severity of adverse reactions. The effectiveness of adding plasma exchange, azathioprine or mycophenolate mofetil to corticosteroids, and combination treatment with tetracycline and nicotinamide needs further investigation." @default.
• W1975843667 created "2016-06-24" @default.
• W1975843667 creator A5073832412 @default.
• W1975843667 date "2012-02-01" @default.
• W1975843667 modified "2023-09-28" @default.
• W1975843667 title "Randomized Controlled Trials Needed for Bullous Pemphigoid Interventions" @default.
• W1975843667 cites W1964267502 @default.
• W1975843667 cites W1981881616 @default.
• W1975843667 cites W2003277956 @default.
• W1975843667 cites W2054414140 @default.
• W1975843667 cites W2072785143 @default.
• W1975843667 cites W2101880291 @default.
• W1975843667 cites W2104410199 @default.
• W1975843667 cites W2134091132 @default.
• W1975843667 cites W2152599151 @default.
• W1975843667 cites W2164385416 @default.
• W1975843667 cites W2388130102 @default.
• W1975843667 cites W2396544847 @default.
• W1975843667 cites W2412172939 @default.
• W1975843667 doi "https://doi.org/10.1001/archdermatol.2011.826" @default.
• W1975843667 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4333149" @default.
• W1975843667 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22351828" @default.
• W1975843667 hasPublicationYear "2012" @default.
• W1975843667 type Work @default.
• W1975843667 sameAs 1975843667 @default.
• W1975843667 citedByCount "3" @default.
• W1975843667 countsByYear W19758436672013 @default.
• W1975843667 countsByYear W19758436672017 @default.
• W1975843667 crossrefType "journal-article" @default.
• W1975843667 hasAuthorship W1975843667A5073832412 @default.
• W1975843667 hasBestOaLocation W19758436672 @default.
• W1975843667 hasConcept C118552586 @default.
• W1975843667 hasConcept C141071460 @default.
• W1975843667 hasConcept C159654299 @default.
• W1975843667 hasConcept C16005928 @default.
• W1975843667 hasConcept C168563851 @default.
• W1975843667 hasConcept C203014093 @default.
• W1975843667 hasConcept C27415008 @default.
• W1975843667 hasConcept C2778075117 @default.
• W1975843667 hasConcept C2779252107 @default.
• W1975843667 hasConcept C71924100 @default.
• W1975843667 hasConceptScore W1975843667C118552586 @default.
• W1975843667 hasConceptScore W1975843667C141071460 @default.
• W1975843667 hasConceptScore W1975843667C159654299 @default.
• W1975843667 hasConceptScore W1975843667C16005928 @default.
• W1975843667 hasConceptScore W1975843667C168563851 @default.
• W1975843667 hasConceptScore W1975843667C203014093 @default.
• W1975843667 hasConceptScore W1975843667C27415008 @default.
• W1975843667 hasConceptScore W1975843667C2778075117 @default.
• W1975843667 hasConceptScore W1975843667C2779252107 @default.
• W1975843667 hasConceptScore W1975843667C71924100 @default.
• W1975843667 hasIssue "2" @default.
• W1975843667 hasLocation W19758436671 @default.
• W1975843667 hasLocation W19758436672 @default.
• W1975843667 hasLocation W19758436673 @default.
• W1975843667 hasLocation W19758436674 @default.
• W1975843667 hasOpenAccess W1975843667 @default.
• W1975843667 hasPrimaryLocation W19758436671 @default.
• W1975843667 hasRelatedWork W1985573384 @default.
• W1975843667 hasRelatedWork W2014329280 @default.
• W1975843667 hasRelatedWork W207790567 @default.
• W1975843667 hasRelatedWork W2211714487 @default.
• W1975843667 hasRelatedWork W2412390337 @default.
• W1975843667 hasRelatedWork W2484963178 @default.
• W1975843667 hasRelatedWork W3154531750 @default.
• W1975843667 hasRelatedWork W3203756424 @default.
• W1975843667 hasRelatedWork W345074830 @default.
• W1975843667 hasRelatedWork W4302412557 @default.
• W1975843667 hasVolume "148" @default.
• W1975843667 isParatext "false" @default.
• W1975843667 isRetracted "false" @default.
• W1975843667 magId "1975843667" @default.
• W1975843667 workType "article" @default.